Analyst Ratings For DexCom (NASDAQ:DXCM)
Today, BMO Capital Markets lowered its price target on DexCom (NASDAQ:DXCM) to $90.00 per share.
There are 3 hold ratings, 15 buy ratings on the stock.
The current consensus rating on DexCom (NASDAQ:DXCM) is Buy (Score: 2.83) with a consensus target price of $87.75 per share, a potential 31.28% upside.
Some recent analyst ratings include
- 8/2/2017-Stephens Reiterated Rating of Overweight.
- 7/14/2017-Cowen and Company Reiterated Rating of Buy.
- 7/12/2017-Piper Jaffray Companies Reiterated Rating of Buy.
- 6/7/2017-Canaccord Genuity Reiterated Rating of Buy.
- On 7/24/2017 Steven Robert Pacelli, EVP, sold 1,450 with an average share price of $69.47 per share and the total transaction amounting to $100,731.50. View SEC Filing
- On 7/12/2017 Kevin R. Sayer, CEO, sold 6,000 with an average share price of $71.86 per share and the total transaction amounting to $431,160.00. View SEC Filing
- On 7/10/2017 Andrew K. Balo, EVP, sold 3,200 with an average share price of $71.55 per share and the total transaction amounting to $228,960.00. View SEC Filing
- On 6/23/2017 Steven Robert Pacelli, EVP, sold 1,450 with an average share price of $78.19 per share and the total transaction amounting to $113,375.50. View SEC Filing
- On 6/12/2017 Andrew K. Balo, EVP, sold 3,200 with an average share price of $69.06 per share and the total transaction amounting to $220,992.00. View SEC Filing
- On 6/12/2017 Kevin R. Sayer, CEO, sold 6,000 with an average share price of $69.07 per share and the total transaction amounting to $414,420.00. View SEC Filing
- On 5/23/2017 Richard Doubleday, EVP, sold 3,182 with an average share price of $68.29 per share and the total transaction amounting to $217,298.78. View SEC Filing
Recent Trading Activity for DexCom (NASDAQ:DXCM)
Shares of DexCom closed the previous trading session at 71.23 up +4.39 6.57% with 1,655,813 shares trading hands.
